National Yang Ming Chiao Tung University

Faculty

  1. Home
  2. Faculty
  3. Faculty
Faculty

Chien, Li-Nien / 簡麗年

Institute of Health & Welfare Policy

 02-2826-7000 #67066
 
 linien.chien@nycu.edu.tw


Current Position

Professor, Institute of Health & Welfare Policy, National Yang Ming Chiao Tung University


Office

Room 615, Nursing Building


Academic Degrees

  1. Ph. D., Institute of Clinical Medicine, National Yang-Ming Medical College1. PhD-Health Service Research and Health Policy (Health Economics Track), Emory University, USA
  2. Mph-Health Policy and Management (Policy Track), Emory University, USA 
  3. MS-Health and Welfare Policy, National Yang-Ming University
  4. BS-Public Health, Fu-Jen Catholic University M. D., Taipei Medical College


Experience

1. Professor-2022/08  – 

Institution of Health and Welfare Policy, NYCU

2. Professor-2022/02 – 2022/07 
Graduate Institute of Data Science, College of Management, TMU
3. Chief-2020/08 – 2022/07 
Health Data Analytics and Statistics Center, Office of Data Science, TMU

4. Professor-2020/08 – 2022/01 

Associate Professor-2017/02 – 2020/07 

Assistant Professor-2012/09 – 2017/01

School of Health Care Administration, College of Management, TMU
5. Post-doctor (Advisor: Professor Hung-Yi Chiou)-2011/01 – 2012/05
School of Public Health and Nutrition, TMU


Specialty

Health service research and program evaluation

 


Research Interests

1. Health claim-based data and complex survey data
2. Health service research and program evaluation
3. Health effectiveness and outcome research
4. Pharmacoepidemiology and economic evaluation
 


Selected Publications

  • 2022
  • Lin SY, Chen YM, Chen WJ, Li A, Ku CK, Chen CH*, Chien LN*. Treatment patterns of long-dose-interval medication for persistent management of osteoporosis in Taiwan. Achieve of Osteoporosis (Accepted, IF= 2.617, 37/82 in ORTHOPEDICS) 
  • Do TP, Chen LY, Chan L, Hu CJ*, Chien LN*. Risk Factors for Post-Ischemic Stroke Epilepsy in Young Adults: A Nationwide Population-Based Study in Taiwan. Frontiers in Neurology (Accepted, IF=4.003, 72/208 in CLINICAL NEUROLOGY)
  • Chou CL, Juan SH, Li CH, Chen HH, Kao CC, Chen LY, Chien LN*, Fang TC*. Association between DPP-4 Inhibitors and Events of Colorectal and Liver Cancers in Patients with Diabetes Receiving Second-line Agents: A Nested Case-control Study. Frontiers in Oncology Front Oncol. 2022 May 6;12:840142. (IF= 6.244, 62/243 in ONCOLOGY)
  • Lin IC, Kuo KY, Liu HY, Chien LN*. Trends in Diagnosed Dry Eye Disease Incidence, 2001-2015: A Nationwide Population-based Study in Taiwan. Cornea 2022;00:1–6 (IF=2.651, 32/62 in OPHTHALMOLOGY)
  • Chien LN, Chen CC, Chang YH, Yu FC, Tsai CT, Liu HY, Yeh HI, Lin CF*. Risk of Heart Failure in Patients with ST-Elevation Myocardial Infraction Receiving Drug-Eluting Stent Implantation and Undefined Duration of Antiplatelets. J. Pers. Med. 2022, 12, 369. (IF=4.945, 15/108 in HEALTH CARE SCIENCES & SERVICES) 
  • Hsiao SH, Chen WT, Chung CL, Chou YT, Lin SE, Hong SY, Chang JH, Chang ZH*, Chien LN*. Comparative survival analysis of platinum-based adjuvant chemotherapy for early-stage squamous cell carcinoma and adenocarcinoma of the lung. Cancer Medicine 2022;00:1–12.  (IF= 4.452, 108/243 in Oncology) 
  • Liang CY, Chiang KL, Hsieh LP*, Chien LN*. Prescription patterns and dosages of antiepileptic drugs in prevalent patients with epilepsy in Taiwan: A nationwide retrospective cross-sectional study. Epilepsy Behav. 2022 Jan;126:108450. (IF= 2.937, 26/53 in BEHAVIORAL SCIENCES)
  • Chien LN, Li YF, Yang RS, Yang TH, Chen YH, Huang WJ, Tsai HY, Li CY, Chan DC*. Real-world cost-effectiveness analysis of the fracture liaison services model of care for hip fracture in Taiwan. J Formos Med Assoc. 2022 Jan;121(1 Pt 2):425-433.  (IF= 3.282, 53/169 in MEDICINE, GENERAL & INTERNAL) (Co-first authors)
  • Hou HA, Tzeng HE, Liu HY, Chou WC, Tien WF, Chien LN*. Effectiveness of induction regimens on survival outcome in acute myeloid leukemia patients: a real-world data from 2001 to 2015. Ann Hematol. 2022 Jan;101(1):109-118. (IF= 3.673, 35/76 in HEMATOLOGY)
  • 2021


  • Chien SC, Hsu CY, Liu HY, Lin CF, Hung CL, Huang CY, Chien LN*. Cardiogenic Shock in Taiwan from 2003 to 2017 (CSiT-15 Study) Critical Care, 2021 (IF=9.097, 5/36 in CRITICAL CARE MEDICINE)
  • Wu MH, Wu Christopher, Lin JH, Chen LY, Lee CY, Huang TJ, Hsieh YC*, Chien LN*. Risk factors for spine reoperation and joint replacement surgeries after short-segment lumbar spinal surgeries for lumbar degenerative disc disease: a population-based cohort study. J CLIN MED (IF=4.241, 39/169 in MEDICINE, GENERAL & INTERNAL)
  • Chiang KL, Liang CY, Hsieh LP*, Chien LN*. Analysis of trends and factors determining initial antiseizure medication choice for epilepsy in Taiwan. Seizure: European Journal of Epilepsy. (IF= 3.187, 109/208 in CLINICAL NEUROLOGY)
  • Chen PC, Chung CC, Cheng YY, Hong CT, Chan L*, Chien LN*. Retinal diseases and Parkinson disease: A population-based study. Front Neurosci. 2021 Aug 30; 15:679092. doi: 10.3389/fnins.2021.679092. eCollection (IF= 4.677, 87/273 in NEUROSCIENCES)
  • Chen CW, Lin YC, Chien LN*, Huang CY*. Association of postdischarge adherence to guideline-directed medical therapy and long-term health outcomes after acute myocardial infarction. J Chin Med Assoc. 2021 Sep 20. doi: 10.1097/JCMA.0000000000000621. Online ahead of print. (IF= 2.743, 62/169 in MEDICINE, GENERAL & INTERNAL)
  • Chen KY, Wu SM, Tseng CH, Lee KY, Lin YH, Liu HY, Chien LN*. Combination therapies with thiazolidinediones are associated with a lower risk of acute exacerbations in new-onset COPD patients with advanced diabetic mellitus: a cohort-based case-control study. BMC Pulm Med 2021 Apr 29;21(1):141. (IF= 3.317, 31/64 in RESPIRATORY SYSTEM)
  • Lin YC, Chen BL, Shih CM, Lin FY, Chen CW, Hsu CY, Kao YT, Bi WF, Chen LY, Chien LN*, Fang TC*, Huang CY*. Effectiveness and safety of rivaroxaban versus warfarin in Taiwanese patients with end-stage renal disease and nonvalvular atrial fibrillation: A real-world nationwide cohort study.  PLoS One. 2021 Apr 8;16(4): e0249940. (IF= 3.240, 26/73 in MULTIDISCIPLINARY SCIENCES)
  • Yeh JS, Hsu CY, Huang CY, Chen WT, Hsieh YC, Chien LN*. The effect of de-escalation of P2Y12 receptor inhibitor therapy after acute myocardial infarction in patients undergoing percutaneous coronary intervention: A nationwide cohort study. PLoS One 2021 Jan 25;16(1): e0246029. (IF= 3.240, 26/73 in MULTIDISCIPLINARY SCIENCES)
  • Lin CF, Chang YH, Yu FC, Tsai CT, Chen CC, Liu HY, Chien LN*. Risk of heart failure following drug-eluting stent implantation in patients with non-ST-elevation myocardial infarction. Atherosclerosis. 2021 Jan; 316:84-89. (IF= 5.162, 14/65 in PERIPHERAL VASCULAR DISEASE)
  • Yu FC, Chang YH, Chen IM, Liu HY, Lin CF*, Chien LN*. Effect of drug-eluting stents on 1-year risk of new-onset atrial fibrillation in patients with acute myocardial infarction treated with percutaneous coronary intervention. Medicine (Baltimore). 2020 Aug 21;99(34): e21885. (IF= 1.889, 99/169 in MEDICINE, GENERAL & INTERNAL)



More in PubMed https://pubmed.ncbi.nlm.nih.gov/?term=Chien+LN